Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03139097 · ClinicalTrials.gov registry record
Reference Range Study for the Quantra Analyzer With the Quantra Surgical Cartridge
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 158
- Enrollment target
NCT03139097 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 158 participants.
The verdict
NCT03139097 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 158 participants
- Enrollment target
Study Summary
This study will establish reference range intervals for the Quantra System, a next-generation diagnostic platform that provides whole blood coagulation testing at the point-of-care.
Interventions
- DIAGNOSTIC_TEST Quantra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2017-01-16 |
| Est. Completion | 2017-09-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03139097
The ClinicalTrials.gov registry entry for NCT03139097 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.
NCT03139097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03139097 about?
NCT03139097 is a clinical study titled "Reference Range Study for the Quantra Analyzer With the Quantra Surgical Cartridge". This study will establish reference range intervals for the Quantra System, a next-generation diagnostic platform that provides whole blood coagulation testing at the point-of-care.
What is the current status of trial NCT03139097?
This trial is currently completed. The enrollment target is 158 participants. The study started on 2017-01-16. Estimated completion is 2017-09-28.
What interventions are being tested in trial NCT03139097?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03139097?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.